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Dithranol has been used for more than 7 5 years in the 
treatment of psoriasis, but although this treatment has 
been very successful, irritation and staining at the sites 
of application remain a limitation.1 In order to counter­
act dithranol-induced irritation, it is important to 
understand its mechanism. As the psoriatic lesion 
itself is far less susceptible to dithranol irritation than 
normal-appearing skin, studies on normal skin are 
indicated, to elucidate the mechanism of dithranol 
irritation.
Irritation following a single application of dithranol is 
characterized by delayed inflammation. After 3 -5  days, 
several markers for the inflammatory response reach 
maximum levels. The response has been characterized
by visual assessment,2,3 laser Doppler flowmetry/ con­
tact thermometry and skin-fold thickness.4 At the 
cellular level, dithranol application to normal skin has 
been shown to induce endothelial cell activation, a 
mixed inflammatory infiltrate, epidermal hyperprolifera­
tion and expression of the hyperproliferation-associated 
keratin 16.6
The aim of the present investigation was to discover 
whether increased epidermal proliferation and abnor­
mal keratinization, which have been reported as com­
ponents of dithranol-induced irritation, are reflected in 
terms of skin barrier function.
Following single applications for 1 h of dithranol 3% 
in petrolatum, dithranol 3% in cream, and dithranol 3%
2
in paste, transepidermal water loss (TEWL), which is a 
reflection of the barrier function of the skin, was 
assessed using evaporimetry. Impairment of the barrier 
function, and an inflammatory reaction, may both 
occur after exposure of the skin to an irritant, but 
they do not always occur together.7 Therefore, the 
irritant reaction was also assessed visually, and by 
colorimetry. Assessment of erythema by colorimetry 
has been used in the past for quantification of 
UV-induced erythema, and erythema induced by sodium 
lauryl sulphate application.8“ 10
Methods
Subjects
Twenty healthy volunteers, without signs or a history of 
skin disease, participated in the study (10 females, 10 
males; age range 1 9 -4 4  years). They all gave written 
informed consent. The experiments were 
from November 1993 to March 1994.
and
Test agents
Dithranol 3% was formulated in cream, 
petrolatum bases. The composition of the vehicles is 
shown in Table 1. These vehicles were also tested with 
regard to irritancy without dithranol.
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Table 1. Vehicles for dithranol
Cream
Cetiol 205 g
Cera cetomacrogolis emulsificans 150 g
Paraffinum subliquidum 1 5 0 g
Acidum salicylicum 1 0 g
Acidum sorbicum 1 • 5 g
Acidum asorbicum 0' 5 g
Aqua demi flltrata ad 1000 g
Paste
Acidum salicylicum 2%
Pasta zinci oxidi
Petrolatum 
Vaseline album
In preliminary experiments, it was shown that a 1 h 
application of this concentration of dithranol induced 
substantial erythema and oedema, but this was toler­
ated by the subjects.
Exposure
Each substance (0-1 ml) was applied within a marked
circle (diameter 1-5 cm) on the volar aspect of the
i
forearm. As there is a site variation in dithranol 
inflammation on forearm skin, applications were per­
formed in a randomized way, according to the Latin 
square principle. After 1 h the substances were removed 
with arachis oil and the skin was washed with soap and 
cold running water.
Two unexposed sites served as controls. Only one of 
these two test sites was treated with the washing 
procedure (control 2), the other control site was kept 
dry (control 1). For practical reasons it was not possible 
to rotate the dry control site according to the Latin 
square principle.
Evaluation
Visual scoring. The clinical changes at the exposure sites 
were determined, for all subjects, after 1, 2, 3 and 4 
days, and rated as follows: 0 =  no erythema; 1 =  
hardly perceptible erythema; 2 =  weak but definite 
erythema; 3 =  marked erythema; 4 =  marked erythema 
with minimal oedema; 5 =  marked erythema with 
marked oedema.
Colorimetric quantification of erythema. A Minolta Chro- 
mameter, model CR-200, was used to measure 
erythema. A colour is expressed in a three-dimensional
coordinate system with an a*-axis (green-red), a 
b*-axis (yellow-blue), and an L-axis (brightness), 
according to the CIE system (Commission Inter­
nationale de l’Eclairage).12 Erythema caused by dithra­
nol application is expected to result in an increase of 
the value on the a*-axis. For all subjects, measure­
ments were performed in duplicate before appli­
cation on day 0, and on the following 4 consecutive 
days, with an interval of 24 h between measurements.
analysis.
Transepidermal water loss. TEWL measurements were 
performed using an evaporimeter (Tewameter TM 210, 
Courage and Khazaka, Köln, Germany). The operating 
principles are described in detail by Nilsson.13 Measure­
ments were performed according to the guide-lines 
described by the Standardization Group of the 
European Society of Contact Dermatitis. Room 
temperature was kept between 20 and 22°C, and 
relative humidity between 38 and 42%.
In nine subjects, TEWL measurements were per­
formed before exposure on day 0, and on the fol­
lowing 4 consecutive days, with intervals of 24 h 
between measurements. Measurements were also 
performed for a longer period in a group of five 
subjects, before exposure on day 0, and on days 2, 4, 
8 and 15.
Statistical analysis
To compare the group means for TEWL and the group 
means for colorimetry, Student’s £-test for paired obser­
vations was used. The Wilcoxon ranking test for 
matched pairs was used to compare the visual scores. 
The association between the visual score and the
was <0*05.
Results
Visual assessment
Figure 1 summarizes the visual scores (mean ±  SEM)
ence was noted between days 0 and 4 for the control 
sites and the vehicles alone. All 3% dithranol formula-
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Figure 1. Visual assessment of erythema (mean ±SEM, n =  20) 
following a single application of dithranol 3% in various vehicles.
, control 1; . cream 3*0%; petrolatum 3*0%;
paste 3-0%.
cream 
days 1 comparison
and 3% dithranol in petrolatum.
Day
Figure 2. Colorimetric assessment of erythema (mean ±  SEM, n = 20) 
following a single application of dithranol 3% in various vehicles.
, cream 3-0%; . petrolatum 3-0%; . paste 3*0%;
control 1.
The correlation between the visual score for 
erythema and the colorimetric measurements was 
statistically significant (R =  0-74, P < 0-05).
Colorimetric assessments
Figure 2 shows that all dithranol test agents caused a 
significant increase in erythema with time. No signifi­
cant increase was noted between days 0 and 4 for the 
control sites and the vehicles. The cream formulation of 
dithranol induced a significantly more pronounced 
erythema than the other two formulations. The dif­
ference between 3% dithranol cream and 3% dith­
ranol paste was significant on days 1 (P < 0-01), 2 
(P <  0-001), 3 (P <  0-001) and 4 (P < 0-001). The 
difference between 3% dithranol cream and 3% dithra­
nol in petrolatum was also significant on days 1
(P<0-01) ,  2 ( P <  0-001), 3 (P <  0-001) and 4
(P < 0-001). There was no difference
between 3% dithranol paste and 3% dithranol in 
petrolatum.
Transepidermal water loss
Table 2 summarizes the TEWL measurements (n = 9 ) 
following dithranol application. The control sites, and 
the sites of application of the vehicles and the 3% 
dithranol formulations did not show any significant 
increase in TEWL during the experimental period of 4 
days.
There was no significant increase in TEWL with any 
of the test agents during the prolonged experiment, at 
any time interval, when treatment and pretreatment 
values were compared (Table 3).
Discussion
From the present study, it can be concluded that 
TEWL did not increase during and following a single
TEWL (mean ±  SEM)
Day 0 Day 1 Day 2 Day 3 Day 4
Control 1 
Cream 3-0% 
Petrolatum 3-0% 
Paste 3-0%
8-4 ± 0 -6
9-4 ± 0 - 7  
9-6 ± 0 -8  
9'1 ±  1-0
9-0 ±  0-6 
10-2 ± 0 - 7  
9-9 ± 0*8  
9-8 ± 0 -9
8-6 ± 0 -4
9-7 ± 0 -7  
9-7 ± 0 -7  
9-4 ±  1-0
8-6 ± 0 - 7
9-7 ± 0 -6  
9-7 ± 0 -9  
8-7 ± 0 -9
8-7 ± 0 -5
9-6 ±  0-6 
10-0 ±  0-9
9-3 ±  1-0
Table 2. Transepidermal water loss (TEWL: 
mean ±  SEM, n —■ 9) following a single 
application of dithranol 3% in various 
vehicles. Follow-up: 4 days
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Table 3. Transepidermal water loss (TEWL; 
mean ±SEM, n — 5) following a single 
application of dithranol 3% in various 
vehicles. Follow-up: 15 days
TEWL (mean ±  SEM)
Day 0 Day 2 Day 4 Day 8 Day 1 5
Control
Cream 3-0% 
Petrolatum 3-0% 
Paste 3-0%
10-0 ±  1-2 
12*3 ±  1-6 
9-8 ± 0 -7  
10-5 ±  1-7
9-4 ±  M  9-0 ± 0 -6  
11*7 ± 1 -2  11 -9 ± 0 4  
9-3 ±  0-8 9-4 ±  0'5 
9-8 ± 1 -3  9-7 ± H )
9-9 ± 0 -7  
12-6 ±0*6  
11 *4 ±  1 '2 
11-5 ±  1-9
10* 3 :fc 1 • I 
12-8 ±  1-2 
10-7 ±  H
101  iO -9
application of dithranol to normal skin, despite pro­
nounced erythema, assessed by subjective visual esti­
mation and quantitative colorimetry. The observation 
that the application of dithranol in the cream formula­
tion induced consistently higher erythema scores sug­
gests that the cream base formulation might enhance 
the percutaneous penetration of dithranol. Such a
penetration-enhancing might counterbalance
application of dithranol, as described in the present 
study, suggests that dithranol
promise the skin barrier, 
repeated applications of dithranol might 
keratinization 
tation potential Further studies using an 
approach of repeated application of 
indicated.
_\s not com-
21', it is possible that
s ïrri- 
imental
the decreased bioavailability of dithranol in cream 
formulations.
In previous studies on the response of normal skin to 
sodium lauryl sulphate, it was demonstrated that con­
centrations producing ‘subclinical irritation’ induced a 
substantial increase of TEWL.15 Hence, the absence of 
modulation of TEWL by dithranol, which was observed 
in the present study, cannot be attributed to insufficient 
sensitivity of the TEWL methodology.
A single appication of dithranol to normal skin has 
been shown to stimulate epidermal proliferation 
(recruitment of cycling epidermal cells), and to induce 
keratin 16 expression in the suprabasal compartment.6 
The present study, however, demonstrates conclusively 
that TEWL is not modulated by dithranol, which implies 
that the skin barrier is not affected by dithranol. From 
this observation, it can be concluded that severe inflam­
mation of the dermoepidermal junction, and substantial 
epidermal proliferation, may occur without any effect 
on the integrity of the skin barrier.
During treatment of psoriatic plaques daily
dithranol applications, TEWL measurements have 
been carried out and compared with TEWL measure­
ments during PUVA treatment.16 TEWL is increased in 
untreated psoriatic plaques, and reverts to normal 
following restoration of the skin barrier. Normalization 
of TEWL occurred after PUVA treatment. Following
dithranol treatment, clinical occurred, but
in contrast with PUVA treatment, TEWL did not nor-
1 f ^
malize. The authors hypothesized ‘It is possible that 
the persistently increased water vapour loss was due to 
the local effect of dithranol on the permeability of the 
stratum corneum in the plaque, occurring in parallel 
with its staining’. The response of normal skin to the
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